Emiliano Bissio

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

Journal: Open forum infectious diseases

Published: March 19, 2026

Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.

Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.

Journal: Viruses

Published: April 07, 2025

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.

Journal: The lancet. HIV

Published: July 09, 2023

Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.

Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.

Journal: Antiviral therapy

Published: February 20, 2017

Very high incidence of syphilis in HIV-infected men who have sex with men in Buenos Aires city: a retrospective cohort study.

Very high incidence of syphilis in HIV-infected men who have sex with men in Buenos Aires city: a retrospective cohort study.

Journal: Sexually transmitted infections

Published: September 21, 2016

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.

Journal: The Journal of antimicrobial chemotherapy

Published: July 17, 2016

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.

Journal: Tissue antigens

Published: September 11, 2014

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.

Journal: Journal of the International AIDS Society

Published: December 12, 2012

Incidence of hyperbilirubinemia and jaundice due to atazanavir in a cohort of Hispanic patients.

Incidence of hyperbilirubinemia and jaundice due to atazanavir in a cohort of Hispanic patients.

Journal: AIDS research and human retroviruses

Published: November 06, 2012

Short communication: fasting increases serum concentrations of bilirubin in patients receiving atazanavir: results from a pilot study.

Short communication: fasting increases serum concentrations of bilirubin in patients receiving atazanavir: results from a pilot study.

Journal: AIDS research and human retroviruses

Published: November 02, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026